mRNA Covid-19 vaccines may boost cancer immunotherapy effectiveness

A retrospective analysis of patients with advanced lung cancer revealed that those vaccinated with an mRNA Covid-19 vaccine had better survival outcomes when taking immune checkpoint inhibitors, compared to unvaccinated patients.

The findings were presented earlier this month at the European Society for Medical Oncology (ESMO) 2024 meeting in Barcelona, Spain.